Compuls-BED-Severity
Reconsidering Severity Classification for Binge Eating Disorder (BED): the Role of Impulsivity, Compulsivity and Co-occurring Disorders
1 other identifier
observational
200
1 country
2
Brief Summary
- Binge Eating Disorder (BED) has been fairly recently introduced into the Diagnostic and Statistical Manual 5 psychiatric classification and its severity criteria are still not well established.
- Moreover, it remains unclear whether BED is associated with greater metabolic severity or more somatic comorbidities, especially in obesity.
- Improved BED severity staging could lead to a better definition of management strategies and , therefore, facilitate screening and care. The investigators' hypothesis is that an improved assessment of the impulsivity-compulsivity spectrum, emotional regulation, attentional impairment and somatic or psychiatric comorbidities will result in a better distinction between the severe form of BED (e.g., highly impulsive and somatically complicated) from milder form (e.g., more compulsive and less somatically complicated).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2021
CompletedFirst Posted
Study publicly available on registry
December 8, 2021
CompletedStudy Start
First participant enrolled
March 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedOctober 9, 2024
October 1, 2024
2.6 years
November 19, 2021
October 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Physical and psychological comorbidities
Number of current associated comorbidities to patient with and without BED
Inclusion
Binge Eating Scale score
To assess binge eating severity based on the 16-item scale developed by Gormally et al in 1982
Inclusion
Secondary Outcomes (18)
Body Mass Index in kg.m-2
Inclusion
Percentage of fat mass in %
Inclusion
Waist and hip circumferences in cm
Inclusion
Triglycerides in mmol/L
Inclusion
Cholesterol HDL and LDL in mmol/L
Inclusion
- +13 more secondary outcomes
Study Arms (2)
BED+ : Participants with obesity and binge eating disorder
Obesity is define by a BMI ≥ 30 kg.m-2 Binge eating disorder is defined by Binge Eating Disorder Screener (BEDS)-7 positive score and a Binge Eating Scale score \>16
BED-: Participants with obesity but without binge eating disorder
Obesity is define by a BMI ≥ 30 kg.m-2 Binge eating disorder is defined by Binge Eating Disorder Screener (BEDS)-7 negative score and a Binge Eating Scale score \< 12
Interventions
(no intervention)
Eligibility Criteria
Patients will be recruited from 2 sites: 1) the Institut Universitaire de Cardiologie et Pneumologie de Québec (IUCPQ; pre-bariatric surgery consultation and obesity care consultation); 2) the Centre d'Expertise Poids, Image et Alimentation (CEPIA), a clinic of the Institute of Nutrition and Functional Foods of Laval University (eatinig disorders consultation). The pre-selection of participants will be done using available data and screening tests deployed through the management frameworks already in place at the two sites. If needed, patients will be recruited by advertisement.
You may qualify if:
- men or women aged 1
- participants eligible for bariatric surgery (BMI\>40, or BMI\>35 with severe comorbidities)
- participants scheduled for medical evaluation and treatment of obesity at the IUCPQ Obesity Clinic (BMI≥30)
- participants scheduled for evaluation and treatment of BED at the CEPIA with obesity (BMI≥30)
- for the group with BED: positive BEDS-7 screen and Binge Eating Scale score \>16;
- for the control group: have a negative BEDS-7 screen and Binge Eating Scale score\<12
- be fluent in French and able to consent.
You may not qualify if:
- participants with severe neurological disorder and/or major neurocognitive deficits;
- participants with previous bariatric surgery or with introduction or change of anti-obesity medication (liraglutide or naltrexone/bupropion) in the previous 3 months;
- participants who cannot read and/or understand French;
- participants under guardianship or curatorship;
- participants already included in a study with a conflict of interest with this study;
- inability to use a computer or iPad;
- participants with a discordance between BEDS-7 (positive) and Binge Eating Scale (score ≤ 16) results found secondarily
- participants who did not participate in part of the assessments (e.g., self-questionnaires or neurocognitive tests) and participants with a rate of missing data\>10%.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre d'expertise Poids, Image et Alimentation (CEPIA)
Québec, Canada
IUCPQ
Québec, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvain Iceta
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 19, 2021
First Posted
December 8, 2021
Study Start
March 7, 2023
Primary Completion
October 1, 2025
Study Completion
December 31, 2025
Last Updated
October 9, 2024
Record last verified: 2024-10